Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11891102rdf:typepubmed:Citationlld:pubmed
pubmed-article:11891102lifeskim:mentionsumls-concept:C0041349lld:lifeskim
pubmed-article:11891102lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:11891102lifeskim:mentionsumls-concept:C0037567lld:lifeskim
pubmed-article:11891102pubmed:issue2lld:pubmed
pubmed-article:11891102pubmed:dateCreated2002-3-13lld:pubmed
pubmed-article:11891102pubmed:abstractTextA severely handicapped 14-year-old Japanese girl had epilepsy and was treated with sodium valproate (SV) from the age of 7 years. Although the epileptic seizures were well controlled, she sometimes had a fever and hypokalemia from the age of 13 years. Laboratory examinations revealed metabolic acidosis, hypouricemia, hypophosphatemia, glycosuria, proteinuria and aminoaciduria, thus suggesting Fanconi syndrome. Gallium scanning showed marked renal uptake. A renal biopsy revealed interstitial nephritis without immuno-deposition. SV was replaced since it was considered to be the most probable cause of the renal involvement. Thereafter, she showed marked improvement of the clinical symptoms and the laboratory data gradually, and she never had a fever. Although SV is an effective anti-epileptic drug, we have to pay attention to adverse renal effects such as Fanconi syndrome and interstitial nephritis.lld:pubmed
pubmed-article:11891102pubmed:languageenglld:pubmed
pubmed-article:11891102pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891102pubmed:citationSubsetIMlld:pubmed
pubmed-article:11891102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891102pubmed:statusMEDLINElld:pubmed
pubmed-article:11891102pubmed:monthMarlld:pubmed
pubmed-article:11891102pubmed:issn0387-7604lld:pubmed
pubmed-article:11891102pubmed:authorpubmed-author:YoshikawaHide...lld:pubmed
pubmed-article:11891102pubmed:authorpubmed-author:WatanabeToruTlld:pubmed
pubmed-article:11891102pubmed:authorpubmed-author:AbeTokinariTlld:pubmed
pubmed-article:11891102pubmed:issnTypePrintlld:pubmed
pubmed-article:11891102pubmed:volume24lld:pubmed
pubmed-article:11891102pubmed:ownerNLMlld:pubmed
pubmed-article:11891102pubmed:authorsCompleteYlld:pubmed
pubmed-article:11891102pubmed:pagination102-5lld:pubmed
pubmed-article:11891102pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:meshHeadingpubmed-meshheading:11891102...lld:pubmed
pubmed-article:11891102pubmed:year2002lld:pubmed
pubmed-article:11891102pubmed:articleTitleTubulo-interstitial nephritis caused by sodium valproate.lld:pubmed
pubmed-article:11891102pubmed:affiliationDepartment of Pediatrics, Niigata City General Hospital, 2-6-1 Shichikuyama 950-8739, Japan. hideto@hosp.niigata.niigata.jplld:pubmed
pubmed-article:11891102pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11891102pubmed:publicationTypeReviewlld:pubmed
pubmed-article:11891102pubmed:publicationTypeCase Reportslld:pubmed